Steve Schram
Advisor, Animal Health
Steve is a seasoned CEO with 40 years of experience in the pharmaceutical and biologics industry. He served as CEO of AgriLabs, where he led acquisitions, co-founded VaxLiant, and secured licensing deals for domestic and international product launches. Under his leadership, AgriLabs developed patented adjuvant technology for DNA vaccines and achieved a successful exit with its sale to Huvepharma in 2017. Earlier, Steve was VP of Sales and Marketing for Norbrook Americas and held various roles at Syntex Animal Health. Skilled in go-to-market strategies, business development, and R&D investments, he has a proven track record in driving growth and innovation in veterinary pharmaceuticals and biologics for the North American market.